Abstract
In this case series of 20 ambulatory and hospitalized adult patients treated for monkeypox virus at a large academic medical center in Chicago, Illinois, tecovirimat use was reserved for those with or at high risk of severe disease, delayed because of logistical and clinical factors, but well tolerated.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 172-174 |
| Number of pages | 3 |
| Journal | Sexually Transmitted Diseases |
| Volume | 50 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 1 2023 |
Funding
Research Electronic Data Capture (REDCap) is supported at the Feinberg School of Medicine by the Northwestern University Clinical and Translational Science Institute, which is supported, in part, by the National Institutes of Health's National Center for Advancing Translational Sciences (grant number UL1TR001422). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
ASJC Scopus subject areas
- Dermatology
- Public Health, Environmental and Occupational Health
- Microbiology (medical)
- Infectious Diseases
